Emi Nishimura

Dr. Kirsner is Chairman, Tenured Professor and the endowed Harvey Blank Chair in the Dr. Phillip Frost Dermatology in the Department of Dermatology and Cutaneous Surgery and Professor of Public Health Sciences at the University of Miami Miller School of Medicine. He is Chief of Dermatology at the University of Miami Hospital and Clinics and Jackson Memorial Hospital and directs the University of Miami Hospital Wound Center. Dr. Kirsner received his undergraduate degree from Texas A&M University, his medical degree from the University of Miami and a PhD in epidemiology from the University of Miami, after he completed his clinical training. His clinical training included internal medicine, a clinical and research fellowship in wound healing and dermatology at the University of Miami. His research interests include Wound Healing and Skin Cancer Epidemiology. Dr. Kirsner serves as one of 3 academic editors for the journal Wound Repair and Regeneration and on the editorial boards for several other journals in dermatology and wound healing. Dr. Kirsner serves in national leadership positions in both Wound Healing and Dermatology, including serving as past Vice President of the American Academy of Dermatology and is currently President of the Wound Healing. In addition to career development awards, foundation, industry sponsored funding and CDC funding, he currently leads or is part of several NIH funded grants. Independent of books, book chapters and abstracts, he has published over 650 articles.

Dr. Chandan K. Sen, PhD, FNAI, is a distinguished figure in regenerative medicine and wound care. He is an elected Fellow of the National Academy of Inventors. Dr. Sen is the inaugural Bartley Griffith Chair in Regenerative Medicine at the Dept. of Surgery and directs the McGowan Institute for Regenerative Medicine at the University of Pittsburgh. He also serves as the Associate Vice Chancellor for Life Sciences Innovation and Commercialization at the University of Pittsburgh. Dr. Sen's leadership focuses on advancing health care research vital to Pittsburgh's future, fostering collaborations with local and national partners, and facilitating the translation of scientific discoveries into practical applications for patients. With a career spanning over three decades, Dr. Sen's research has been instrumental in developing innovative solutions for tissue injury, regeneration, and infection management. Notable breakthroughs include pioneering technologies such as tissue nanotransfection and electroceutical infection management. He is the current vice-chair and chair-elect of the national NIH-funded Diabetic Foot Consortium. Dr. Sen's contributions have earned prestigious recognitions, including the 2018 Edison Award for Innovation and the 2016 Frost & Sullivan Award for New Product Innovation. With an extensive publication record, Dr. Sen’s work has been cited over 55000 times in the literature with current H-index 119.